Immune Cells, Gene Therapy, and Engineered Tissues
Kilder
- Nature: Long-lived immune cells show promise against cancer in world-first trial - Nature
- Statnews: What does Akeso’s primo plenary spot say about its survival data? - statnews.com
- statnews.com: What does Akeso’s primo plenary spot say about its survival data? - statnews.com
- fiercebiotech.com: Leo Pharma pays $50M for Replay and its preclinical skin disease gene therapy - Fierce Biotech
- bioworld.com: Dermatology specialist Leo Pharma makes a $50M move into gene therapy - BioWorld News
- Biospace: Patient death prompts FDA pause on Newron’s Phase 3 schizophrenia study - BioSpace
- biospace.com: Patient death prompts FDA pause on Newron’s Phase 3 schizophrenia study - BioSpace
- biospace.com: Newron Reports a Pause of Enrollment of New Study Participants in US Centers of ENIGMA-TRS 2 Study - BioSpace
- Bioworld: EQ-504 is AhR agonist for ulcerative colitis, related disorders - BioWorld News
- Nature: This organoid can menstruate — and shows how tissue can repair itself - Nature
- wikimedia: Photo by Encik Tekateki / Wikimedia Commons / CC BY-SA 4.0
Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.